학술논문
Natural antibodies to non-human glycans Neu5Gc and alpha-gal correlate with outcome of high-risk neuroblastoma patients treated with dinutuximab on COG ANBL0032 and ANBL0931
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15387445